Nautilus Biotechnology, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Nautilus Biotechnology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2025.
  • Nautilus Biotechnology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2025 was -$15M, a 16.5% increase year-over-year.
  • Nautilus Biotechnology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2025 was -$65.7M, a 5.68% increase year-over-year.
  • Nautilus Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$70.8M, a 11.2% decline from 2023.
  • Nautilus Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$63.7M, a 9.93% decline from 2022.
  • Nautilus Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$57.9M, a 15.1% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 -$15M +$2.98M +16.5% Jun 30, 2025 10-Q 2025-07-31
Q1 2025 -$16.6M +$2.12M +11.3% Mar 31, 2025 10-Q 2025-04-29
Q4 2024 -$17.6M -$570K -3.35% Dec 31, 2024 10-K 2025-02-27
Q3 2024 -$16.4M -$568K -3.58% Sep 30, 2024 10-Q 2024-10-29
Q2 2024 -$18M -$2.2M -13.9% Jun 30, 2024 10-Q 2025-07-31
Q1 2024 -$18.7M -$3.77M -25.2% Mar 31, 2024 10-Q 2025-04-29
Q4 2023 -$17M -$3.62M -27% Dec 31, 2023 10-K 2025-02-27
Q3 2023 -$15.9M -$1.82M -12.9% Sep 30, 2023 10-Q 2024-10-29
Q2 2023 -$15.8M -$1.12M -7.62% Jun 30, 2023 10-Q 2024-07-30
Q1 2023 -$15M +$798K +5.06% Mar 31, 2023 10-Q 2024-04-30
Q4 2022 -$13.4M +$3.28M +19.7% Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$14.1M +$441K +3.04% Sep 30, 2022 10-Q 2023-10-31
Q2 2022 -$14.7M -$3.98M -37.1% Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$15.8M -$7.35M -87.5% Mar 31, 2022 10-Q 2023-05-02
Q4 2021 -$16.7M -$8.4M -101% Dec 31, 2021 10-K 2023-02-23
Q3 2021 -$14.5M -$10.5M -265% Sep 30, 2021 10-Q 2022-11-01
Q2 2021 -$10.7M -$7.36M -219% Jun 30, 2021 10-Q 2022-08-02
Q1 2021 -$8.41M -$8.41M Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$8.29M Dec 31, 2020 10-K 2022-02-24
Q3 2020 -$3.98M Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$3.36M Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $0 Mar 31, 2020 10-Q 2020-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.